Our mission is to become a worldwide reference for education in the field for all professionals involved in the process to disseminate knowledge & skills of Acute Cardiovascular Care.
Our mission is to promote excellence in clinical diagnosis, research, technical development, and education in cardiovascular imaging in Europe.
Our mission is to promote excellence in research, practice, education and policy in cardiovascular health, primary and secondary prevention.
Our mission is to reduce the burden of cardiovascular disease through percutaneous cardiovascular interventions.
Improving the quality of life and reducing sudden cardiac death by limiting the impact of heart rhythm disturbances.
Our mission is to improve quality of life and longevity, through better prevention, diagnosis and treatment of heart failure, including the establishment of networks for its management, education and research.
The ESC Working Groups' goal is to stimulate and disseminate scientific knowledge in different fields of cardiology.
The ESC Councils' goal is to share knowledge among medical professionals practising in specific cardiology domains.
OUR MISSION: TO REDUCE THE BURDEN OF CARDIOVASCULAR DISEASE
The Heart Failure Association believes that it is crucial to provide high-quality educational material to its members and to the international medical community in general. To this end, the HFA has decided to enrich its educational offer via a series of interactive, online courses to improve the implementation of the latest guidelines on diagnosis, treatment and management of heart failure.
The goal is to improve the implementation of the latest heart failure guidelines regarding diagnosis, treatment and management of patients. The format will be interactive e-learning courses, accredited for Continuing Medical Education (CME), that will be hosted on the HFA website and accessible for all online and full HFA members.
View the catalogue
These courses feature various multimedia elements to enhance your learning experience, including expert interviews, animations and multiple choice questions. All courses have been developed with an improved outcomes-oriented approach and generate an integrated learner assessment as well as feedback overview. The e-modules can be accessed and taken at your convenience, offering you a useful educational resource at all times.
Diagnosis of HF
Symptoms and health-related quality of life in chronic heart failure
How to use diuretics in HF
How to use ACE inhibitors & ARBs in HF
How to use beta-blocker in Heart Failure patients
Mineralocorticoid Receptor Antagonists in Heart Failure
A basic understanding of heart rate and heart rhythm in HF
Indications for/and use of a CRT (not yet available)
Co-morbidities in HF 1: secondary prevention in HF
Co-morbidities in HF 2: anaemia & iron deficiency
Exercise training in HF
Advanced Chronic Heart Failure: Definition, epidemiology, clinical characteristics
ESC Heart Failure Guidelines 2012: What's New?
Best papers 2012
Heart failure with preserved ejection fraction (HFpEF)
Use of natriuretic peptides in the management of heart failure
Imaging in heart failure: basic concepts
Acute heart failure
Indications for and use of an ICD
Co-morbidities in HF 3: atrial fibrillation
Co-morbidities in HF 4: angina and acute coronary syndromes
Co-morbidities in HF 5: Chronic obstructive pulmonary disease (COPD) in Heart Failure
Left ventricular assist device (LVAD) support in heart failure patients
Travelling with heart failure
Disease Management Programmes in heart failure
Treating heart failure earlyValvular Heart Disease
Risk Stratification in HF Patients
All interactive, e-learning modules will be submitted for accreditation for Continuing Medical Education (CME) by the European Board for Accreditation in Cardiology (EBAC).All learners who successfully complete the courses will be eligible to receive 2 CME credits. Clinical cases receive 1 CME credit.
The Heart Failure Association of the European Society gratefully acknowledges the contribution of the following companies who have supported the wave one educational modules via an unrestricted grant. Sponsors have in no way contributed to or influenced the scientific content of these educational modules.
Abbott Products Operations AG - Servier - Thoratec Europe Limited – Pfizer Limited - Vifor Pharma - Edwards Lifesciences
G. Rosano (Italy) Email
Gerasimos Filippatos (Greece)Offer Amir (Israel)Mitja Lainscak (Slovenia)Stephan von Haehling (Germany)Julia Grapsa (UK)Andrew Coats (UK)
Y Colardelle Observer
Affiliated: S D Anker (Germany)
© 2017 European Society of Cardiology. All rights reserved